# Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

> **NCT00013520** · PHASE3 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1125 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Abacavir sulfate, Lamivudine and Zidovudine
- **DRUG:** Atazanavir
- **DRUG:** Lamivudine/Zidovudine
- **DRUG:** Abacavir sulfate
- **DRUG:** Efavirenz
- **DRUG:** Nevirapine
- **DRUG:** Lamivudine
- **DRUG:** Stavudine
- **DRUG:** Zidovudine
- **DRUG:** Didanosine

## Key facts

- **NCT ID:** NCT00013520
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2005-06
- **Target enrollment:** 1125 (—)
- **Last updated:** 2012-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00013520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00013520, "Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00013520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*